Hippocratic AI logo

ARR Leaderboard

Hippocratic AI ARR: ~$50M+ at the Safety-First Frontier.

Hippocratic AI builds patient-facing clinical agents and has never precisely disclosed revenue — it is carried here at an estimated ~$50M+ threshold, backed by a $3.5B Series C valuation and 10 million patient calls. The timeline below mixes funding milestones with clearly flagged third-party estimates.

~$50M+

Estimated ARR, 2026

10M+

Patient calls completed

$3.5B

Valuation, Series C Nov 2025

$404M

Total funding raised

The Hippocratic AI Revenue Curve.

Estimated annualized run rate in USD millions, 2024 to 2026. ARR is not precisely disclosed; earlier points are illustrative third-party estimates, and the company's funding rounds are marked on the same axis.

$0M$15M$30M$45M$60M2023 — $2M ARR2024 — $5M ARRJanuary 2025 — $15M ARRNovember 3, 2025 — $35M ARR2026 — $50M ARR20232024Jan '25Nov '252026
Sources: Hippocratic AI, SiliconANGLE, Fierce Healthcare, Presenc AI. Estimates are not company disclosures.

Founded → unicorn

~18 months

2023 → Jan 2025

Unicorn → $3.5B valuation

10 months

Jan 2025 → Nov 2025

0 → 10M patient calls

~2 years

Launch → 2026

ARR disclosure

Never published

Carried at $50M estimate

Every Reported ARR Milestone.

  1. 2023

    $2M ARR

    Founded by Munjal Shah with a safety-focused LLM for healthcare; revenue negligible. Illustrative estimate only. Company (founding); ARR illustrative

  2. 2024

    $5M ARR

    Early hospital pilots for patient-facing non-diagnostic agents. Illustrative estimate — ARR not disclosed. Estimate

  3. January 2025

    $15M ARR

    $141M Series B at a $1.64B valuation makes Hippocratic a unicorn; an agent app store lets clinicians build their own agents. Fierce Healthcare

  4. November 3, 2025

    $35M ARR

    $126M Series C at a $3.5B valuation led by Avenir Growth; total funding reaches $404M. ARR still undisclosed. Hippocratic AI / SiliconANGLE

  5. 2026

    $50M ARR

    Estimated at the ~$50M threshold as the company passes 10 million patient calls and expands into nurse workflows and life sciences. Third-party estimate. Presenc AI (estimate)

Hippocratic AI by the Numbers.

Latest ARR

~$50M+ (estimated)

Presenc AI estimate; not disclosed

Valuation (Series B)

$1.64B

Series B, Jan 2025

Valuation (Series C)

$3.5B

Series C, Nov 2025

Total raised

$404M

Six rounds through Nov 2025

Patient calls

10M+

Company, 2026

How Hospitals Pay Agents by the Interaction.

Hippocratic AI sells patient-facing clinical agents to hospitals and health systems on enterprise contracts — agents that handle non-diagnostic tasks like appointment prep, medication reminders, follow-up check-ins and chronic-care outreach, staffed against the roughly 1.2 million-nurse shortfall in the U.S. Healthcare organizations pay per deployment and per interaction volume rather than per seat.

The 2025 app store opened a second channel: clinicians design and publish their own agents, and Hippocratic takes the underlying platform spend. Series C funds were earmarked for M&A, product development and international expansion — a signal that the company is consolidating the patient-communication stack while revenue remains below disclosure scale.

Revenue Mix

  • Hospital enterprise contractsPer-deployment and per-interaction pricing for patient-facing agents.
  • Agent app storeClinician-built agents monetized through the platform.
  • Life sciences expansionPharma-facing agents for outreach and trials, added post-Series C.

FAQ

Hippocratic AI Revenue, Answered.

What Is Hippocratic AI's ARR in 2026?
Hippocratic AI has not precisely disclosed its ARR. It is carried here at an estimated ~$50 million threshold, consistent with third-party research; the company's most concrete traction numbers are 10 million+ patient calls and a $3.5 billion valuation.
Why Is Hippocratic AI's Revenue Only an Estimate?
The company has never published revenue, margin or burn figures. Its funding rounds — $141M Series B at $1.64B in January 2025 and $126M Series C at $3.5B in November 2025 — are the primary public signals, and analysts derive revenue context from those multiples.
How Does Hippocratic AI Make Money?
Enterprise contracts with hospitals and health systems for patient-facing, non-diagnostic agents — priced per deployment and per interaction — plus an app store where clinicians build agents and Hippocratic monetizes the underlying platform usage.
What Is Hippocratic AI's Valuation?
$3.5 billion after a $126 million Series C led by Avenir Growth on November 3, 2025, up from $1.64 billion at the January 2025 Series B. Total funding stands at $404 million across six rounds.
What Does Hippocratic AI Actually Do?
It builds safety-focused generative AI agents for patient-facing healthcare communication — appointment prep, medication reminders, follow-ups and chronic-care check-ins — positioned against the roughly 1.2 million-nurse shortage in U.S. healthcare, with expansion into nurse workflows and life sciences in 2026.

Building Healthcare Agents? Monetize Every Interaction.

Clink bills healthcare agents by the interaction — enterprise contracts, usage invoicing and merchant-of-record tax handling for clinical AI deployments.

Bill Healthcare Agents